{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "NCT02742844",
            "NStudiesAvail": 430108,
            "NStudiesFound": 1,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 1,
            "FieldList": [
                  "ResultsFirstSubmitDate",
                  "ResultsFirstSubmitQCDate",
                  "RetractionPMID",
                  "RetractionSource",
                  "SamplingMethod",
                  "SecondaryId",
                  "SecondaryIdDomain",
                  "SecondaryIdLink",
                  "SecondaryIdType",
                  "SecondaryOutcomeDescription",
                  "SecondaryOutcomeMeasure",
                  "SecondaryOutcomeTimeFrame",
                  "SeeAlsoLinkLabel",
                  "SeeAlsoLinkURL",
                  "SeriousEventAssessmentType",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Percentage of wound size reduction at Weeks 2, 3, 4, 6, 8, 10 and 12 (without LOCF)",
                              "A priori specification not possible",
                              "A priori specification not possible",
                              "Amount of wound epithelialization in % of wound area will be assessed by the investigator based on image analysis of images taken from the wound.",
                              "Formation of granulation tissue in % of wound area will be assessed by the investigator based on image analysis of images taken from the wound.\n\nWound exudation will be classified by the investigator using following scores:\n\nHigh: Small amounts of fluid or free fluids are visible when the dressing is removed; dressing is extensively marked or wet\nModerate: Small amounts of fluid are visible when dressing is removed; wound bed may appear glossy; Primary dressing may be lightly marked\nLow: Wound bed is dry; there is no visible moisture; Primary dressing is unmarked; dressing may be adherent to wound"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Percentage of wound size reduction",
                              "Absolute wound size reduction",
                              "Proportion of patients achieving complete wound closure",
                              "Time to first complete wound closure",
                              "Proportion of patients achieving 30% wound closure",
                              "Time to first 30% wound closure",
                              "Percentage of wound epithelialization",
                              "Formation of granulation tissue and wound exudation",
                              "Pain assessment as per numerical rating scale (NRS)",
                              "Quality of life (QoL) assessment using the SF-36 questionnaire",
                              "Dermatologic quality of life assessment using the DLQI questionnaire",
                              "Physical examination and vital parameters"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "Weeks 2, 3, 4, 6, 8, 10 and 12 post baseline",
                              "Weeks 2, 3, 4, 6, 8, 10, and 12 post baseline",
                              "Weeks 2, 3, 4, 6, 8, 10, and 12 post baseline and at any time point up to week 12",
                              "Between baseline and week 12 post baseline",
                              "Weeks 2, 3, 4, 6, 8, 10, 12 post baseline and at any time point up to week 12",
                              "Between baseline and week 12 post baseline",
                              "At baseline and days 3, 8 and weeks 2, 3, 4, 6, 8, 10, 12 post baseline",
                              "At baseline and days 3, 8 and weeks 2, 3, 4, 6, 8, 10, 12 post baseline",
                              "At baseline and days 1-3, 8 and weeks 2, 3, 4, 6, 8, 10, 12 post baseline",
                              "At baseline and weeks 4, 8, 12 post baseline",
                              "At baseline and weeks 4, 8, 12 post baseline",
                              "At Screening, baseline, week 12, month 12"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT02742844"
                        ]
                  }
            ]
      }
}